Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

Coinbase Q4 Earnings & Revenues Miss Estimates on Higher Expenses
Coinbase Q4 Earnings & Revenues Miss Estimates on Higher Expenses

Coinbase Global, Inc. COIN reported fourth-quarter 2025 net operating earnings per share of 66 cents, which missed the Zacks Consensus Estimate by 28.2%. The bottom line declined 80.4% year over

Near-Perfect CPI Report Brings Pre-Markets Near BreakevenPhoto, wide shot, wide-angle lens,  Software company, sunset photo at golden hour, photo by Marc Adamus: https://img.theapi.app/temp/9d624ad0-0157-4808-b12c-caf136345180.png
Near-Perfect CPI Report Brings Pre-Markets Near Breakeven

Friday, February 13th, 2026As far as economic reports go, the good news just keeps on coming. Seemingly running on a separate track from investor fears about AI’s future role in the economy, today’s

Palo Alto Networks to Report Q2 Earnings: How to Play the Stock
Palo Alto Networks to Report Q2 Earnings: How to Play the Stock

Palo Alto Networks, Inc. PANW is scheduled to report its second-quarter fiscal 2026 results on Feb. 17.

Palo Alto Networks projects its fiscal second-quarter revenues in the range of $2.57-$2.59

What Fueled KEY's NII Expansion in 2025 Despite Easing Rates
What Fueled KEY's NII Expansion in 2025 Despite Easing Rates

KeyCorp’s KEY net interest income (NII) (on a tax-equivalent or TE basis) increased 23% year over year to $4.67 billion in 2025. The growth was fueled by strong commercial loan expansion, improved

Agios Pharmaceuticals Incurs Narrower-Than-Expected Q4 LossPhoto, wide shot, wide-angle lens,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png
Agios Pharmaceuticals Incurs Narrower-Than-Expected Q4 Loss

Agios Pharmaceuticals AGIO reported a loss of $1.85 per share in the fourth quarter of 2025, narrower than the Zacks Consensus Estimate of a loss of $1.97. In the year-ago quarter, the company had

ABM Banks on Multi-Year Strategic Plan ELEVATE Amid Macroeconomic RiskPhoto, wide shot, wide-angle lens,  Consumer electronics manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://img.theapi.app/temp/d8a4268f-c982-4aa8-a09e-f9ee1db62f57.png
ABM Banks on Multi-Year Strategic Plan ELEVATE Amid Macroeconomic Risk

ABM Industries’ ABM top line is gaining from its multi-year comprehensive strategic plan, ELEVATE, enhancing transparency and efficiency. Rising AI investments through acquisitions are expanding its

Technological Investments & Acquisitions Aid Aptiv Amid Low LiquidityPhoto, wide shot, wide-angle lens, soft focus,  Car manufacturer, sunset photo at golden hour, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-iZxNvwmEDAT2zuvMswp8MrIk.png?st=2023-05-08T05%3A56%3A42Z&se=2023-05-08T07%3A56%3A42Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T03%3A27%3A06Z&ske=2023-05-09T03%3A27%3A06Z&sks=b&skv=2021-08-06&sig=hpaom2wRNOR4VGolGAMc0MX1MdH9zOmjK0MSBHrfkTo%3D
Technological Investments & Acquisitions Aid Aptiv Amid Low Liquidity

Aptiv Plc’s APTV top line benefits from its selected acquisitions and strategic investments to leverage growing electrification, connectivity and autonomy trends in the rapidly evolving automotive

PacBio Q4 Earnings and Revenues Beat Estimates, Gross Margin Up
PacBio Q4 Earnings and Revenues Beat Estimates, Gross Margin Up

Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, delivered an adjusted loss per share of 12 cents in fourth-quarter 2025, narrower than the year-ago adjusted loss of 20 cents

Alliant Energy to Post Q4 Earnings: What to Expect From the Stock?
Alliant Energy to Post Q4 Earnings: What to Expect From the Stock?

Alliant Energy LNT is scheduled to release fourth-quarter 2025 results on Feb. 19, after market close. The company delivered a negative earnings surprise of 4.27% in the last reported quarter.Let’s

Ultragenyx Q4 Loss Wider Than Expected, Revenues Increase Y/YPhoto, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/0e9d087d-988e-4397-b7cf-6049e2776769.png
Ultragenyx Q4 Loss Wider Than Expected, Revenues Increase Y/Y

Ultragenyx Pharmaceutical RARE reported fourth-quarter 2025 loss of $1.29 per share, wider than the Zacks Consensus Estimate of a loss of $1.20. The company had incurred a loss of $1.39 per share in

Penske Q4 Earnings Miss Expectations, Dividend RaisedPhoto, wide shot, wide-angle lens, soft focus,  Auto parts supplier, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-XjwbnkgTrFCFx6Y3gLbqZBCj.png?st=2023-05-13T09%3A21%3A52Z&se=2023-05-13T11%3A21%3A52Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-13T06%3A55%3A39Z&ske=2023-05-14T06%3A55%3A39Z&sks=b&skv=2021-08-06&sig=wJlbn/o%2BieTjclaQNRsJc%2BDDZieC0UCS6BPi5tapxAA%3D
Penske Q4 Earnings Miss Expectations, Dividend Raised

Penske Automotive Group PAG reported fourth-quarter 2025 adjusted earnings of $2.91 per share, which decreased 17.8% year over year and missed the Zacks Consensus Estimate of $3.19. The company

Here's Why Boot Barn's Store Expansion Strategy Looks Compelling
Here's Why Boot Barn's Store Expansion Strategy Looks Compelling

Boot Barn Holdings, Inc. BOOT continues to generate strong results from its new store engine, consistently surpassing expectations for sales, earnings, and payback across all U.S. regions. This

NVS Reports Positive Late-Stage Data on Kidney Disease Drug Vanrafia
NVS Reports Positive Late-Stage Data on Kidney Disease Drug Vanrafia

Novartis NVS announced positive results from the late-stage III ALIGN study on kidney disease drug Vanrafia (atrasentan).

The ALIGN study is a global, randomized, multicenter, double-blind

ALNY Q4 Earnings Beat, Sales Miss Despite Y/Y Growth, Stock DownPhoto, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
ALNY Q4 Earnings Beat, Sales Miss Despite Y/Y Growth, Stock Down

Alnylam Pharmaceuticals ALNY reported fourth-quarter 2025 adjusted earnings of $1.25 per share, beating the Zacks Consensus Estimate of $1.16. The company had reported adjusted earnings of 6 cents

Mortgage-Backed Securities ETF (VMBS) Touches New 52-Week HighPhoto, wide shot, wide-angle lens,  Hedge fund, neutral atmosphere, photo by Charlie Waite: https://img.theapi.app/temp/95282efd-f725-49c0-be40-aa74627f7ccc.png
Mortgage-Backed Securities ETF (VMBS) Touches New 52-Week High

For investors seeking momentum, the Vanguard Mortgage-Backed Securities ETF VMBS is probably on the radar now. The fund just hit a 52-week high and is up 6% from its 52-week low price of $44.85 per

ETFs to Gain as US & Taiwan Sign Trade Deal to Reduce Tariffs to 15%Photo, wide shot, wide-angle lens,  Metal fabrication, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.midjourneyapi.xyz/temp/138548fd-aba2-4b3e-b9ee-93725b372952.png
ETFs to Gain as US & Taiwan Sign Trade Deal to Reduce Tariffs to 15%

The landmark trade agreement signed between the United States and Taiwan on Feb. 12, 2026, has ignited a new wave of optimism for the island’s industrial powerhouses. By reducing reciprocal tariffs

Does Rigetti's $600M Cash Runway De-Risk Its 2026 Roadmap Execution?
Does Rigetti's $600M Cash Runway De-Risk Its 2026 Roadmap Execution?

Rigetti Computing RGTI moves into 2026 with one of the strongest balance sheets in the pure-play quantum universe, a position that materially differentiates it from peers still dependent on frequent

ASML Climbs 11% in a Month: Time to Buy, Sell or Hold the Stock?Photo, wide shot, wide-angle lens,  Consumer electronics manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://img.theapi.app/temp/d8a4268f-c982-4aa8-a09e-f9ee1db62f57.png
ASML Climbs 11% in a Month: Time to Buy, Sell or Hold the Stock?

ASML Holding ASML shares have surged 11.3% in the past month, outperforming the Zacks Computer and Technology sector’s decline of 3.4%. ASML stock has also outperformed its peers, namely Lam

Iron Mountain Q4 AFFO Beat, Storage Rental & Service Revenues Rise
Iron Mountain Q4 AFFO Beat, Storage Rental & Service Revenues Rise

Iron Mountain Incorporated’s IRM fourth-quarter 2025 adjusted funds from operations (AFFO) per share of $1.44 outpaced the Zacks Consensus Estimate of $1.39. Total revenues of $1.84 billion

APLD's Energy Strategy is Evolving: Can it Drive Further Upside?
APLD's Energy Strategy is Evolving: Can it Drive Further Upside?

Applied Digital APLD is enhancing its competitive edge by treating energy availability as a strategic asset rather than a passive input. Through its collaboration with Babcock and Wilcox Enterprises

Should Altria Stock Be Part of Your Portfolio Post Q4 Earnings?
Should Altria Stock Be Part of Your Portfolio Post Q4 Earnings?

Altria Group, Inc. MO delivered a resilient fourth-quarter 2025 performance, highlighting the durability of its business model despite persistent cigarette volume declines and regulatory

TRIP's Q4 Earnings Miss Estimates, Hotel Weakness Drags ResultsPhoto, wide shot, wide-angle lens,  Retail store, Midday, harsh overhead sunlight, directional sunlightt, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/add1012b-1b24-4eb2-aba0-77ab52c7f8ad.png
TRIP's Q4 Earnings Miss Estimates, Hotel Weakness Drags Results

Tripadvisor Inc. TRIP reported fourth-quarter 2025 non-GAAP earnings of 4 cents per share, missing the Zacks Consensus Estimate of 9 cents per share by 73.33%. The figure increased 33.33% year over

CRSP Posts Wider-Than-Expected Loss in Q4, Sales Miss Estimates
CRSP Posts Wider-Than-Expected Loss in Q4, Sales Miss Estimates

CRISPR Therapeutics CRSP reported a fourth-quarter 2025 loss of $1.37 per share, wider than the Zacks Consensus Estimate of a loss of $1.15. The company had incurred a loss of 44 cents per share in

Best Growth Stocks to Buy for February 13th
Best Growth Stocks to Buy for February 13th

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today February 13th:

LATAM Airlines Group LTM: This Latin America’s leading airline company, which

Nu Skin Enterprises Q4 Earnings Lag Estimates, Revenues Down Y/Y
Nu Skin Enterprises Q4 Earnings Lag Estimates, Revenues Down Y/Y

Nu Skin Enterprises, Inc. NUS posted fourth-quarter 2025 results, with the top and bottom lines missing the Zacks Consensus Estimate. Earnings and net sales declined year over year. In the fourth